Improving the process and outcome of care in COPD: Development of a standardised assessment tool

Primary Care Respiratory Journal

Volumn 18, Issue 3, 2009, Pages 208-215

  Jones, Paul ^a   Harding, Gale ^b   Wiklund, Ingela ^c   Berry, Pamela ^c   Leidy, Nancy ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease (COPD); Health status assessment; Optimal management; Questionnaire

Indexed keywords

SALBUTAMOL;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; COUGHING; DYSPNEA; ENERGY; EVALUATION; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; QUALITATIVE RESEARCH; SLEEP; SOCIAL STATUS; WHEEZING;

AGED; BRONCHITIS, CHRONIC; FEMALE; FOCUS GROUPS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 69749093008     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2009.00053     Document Type: Article

References (22)

1. WHO. COPD: Burden. World Health Organization [Online] http://www.who.int/respiratory/copd/burden/en/index.html
2. National Center for Health Statistics, National Health Interview Survey, 1982-1996, 1997-2002. Information cited in: American Lung Association, Epidemiology and Statistics Unit. Trends in Chronic Bronchitis and Emphysema: Morbidity and Mortality. April 2004.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504. http://dx.doi.org/10.1016/S0140-6736(96)07492-7502
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2007:1-30. http://www.goldcopd.com/GuidelinesResources.asp
5. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society. Am J Respir Crit Care Med 1995;152 Suppl;S77-121.
6. Siafakas NM, Vermeire P, Price NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-1420
7. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic Obstructive Pulmonary Disease Surveillance - United States, 1971-2000. MMWR Surveill Summ 2002;51(6):1-16. U.S. Department of Health and Human Services, Atlanta, GA 30333, Centers for Disease Control and Prevention.
8. American Association for Respiratory Care. Confronting COPD in America: Executive Summary. http://www.aarc.org/resources/confronting- copd/exesum.pdf
9. Rennard S, Decramer M, Calverley PMS, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805. http://dx.doi.org/10.1183/ 09031936.02.03242002
10. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946 http://dx.doi.org/10.1183/09031936.04.00014304 (Pubitemid 38807371)
11. Jansson SA, Andersson F, Borg S, et al. Costs of COPD in Sweden according to disease severity. Chest 2002;122(6):1994-2002. http://dx.doi.org/10.1378/ chest.122.6.1994 (Pubitemid 36051135)
12. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85 Suppl B:25-31; discussion 3-7.
13. Larson JL, Covey MK, Berry JK, et al. Reliability and validity of the Chronic Respiratory Disease Questionnaire. Am Rev Respir Dis 1993;147:A530.
14. van der Molen T, Willemse BW, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13. http://dx.doi.org/10.1186/1477-7525-1-13 (Pubitemid 39111983)
15. Bailey WC, Sciurba FC, Hanania NA, et al. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Resp J 2009;18(3):198-207. http://dx.doi.org/10.4104/ pcrj.2009.00032
16. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65. http://dx.doi.org/10.1016/j.jaci.2003.09.008 (Pubitemid 38096162)
17. BTS guidelines for the management of chronic obstructive pulmonary disease: The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52 Suppl 5:S1-28.
18. National Institute for Health and Clinical Excellence (NICE). Clinical Guidelines for Chronic Obstructive Pulmonary Disease. http://www.nice.org.uk/ Guidance/CG12
19. Miravitlles M, Anzueto A, Legnani D, et al. Patient's perception of exacerbations of COPD - the PERCEIVE study. Respir Med 2007;101:453-460 http://dx.doi.org/10.1016/j.rmed.2006.07.010 (Pubitemid 46196335)
20. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31(2):416-469 http://dx.doi.org/10.1183/09031936.00099306
21. Food and Drug Administration (FDA). Guidance for Industry, Patient-Reported Outcomes Measures: Use in Medical Product Development to Support Labeling Claims. http://www.fda.gov/cder/guidance/index.htm
22. Commissioning for Quality and Innovation Scheme (CQUINS). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPoli cyAndGuidance/DH-091443 Downloaded 25 February 2009.